bioRxiv preprint doi: https://doi.org/10.1101/2021.01.19.427265; this version posted January 20, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. H2A.B is a cancer/testis factor involved in activation of ribosome biogenesis in Hodgkin Lymphoma Xuanzhao Jiang1, Jiayu Wen1, Elizabeth Paver2, Wu, Yu-Huan1,3, Gege Sun1,4, Amanda Bullman5, Jane E. Dahlstrom5,6, David J. Tremethick1* and Tatiana A. Soboleva1* 1The John Curtin School of Medical Research, The Australian National University, Canberra, ACT, Australia. 2 Department of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, Australia. 3 Current address: IQVIA Solutions Taiwan Ltd. 105, Taiwan, Taipei City, Songshan District, Section 3, Minsheng East Road, 13, Taipei City, Taiwan. 4 Current address: Department of Applied Biology and Chemical Technology and State Key Laboratory of Chemical Biology and Drug Discovery, Hong Kong Polytechnic University, Hong Kong SAR, China. 5 Department of Anatomical Pathology, ACT Pathology, The Canberra Hospital, Canberra, ACT, Australia. 6 Australian National University Medical School, The Australian National University, Canberra, ACT, Australia. *Corresponding co-authors
[email protected] [email protected] Running title: H2A.B enhances Pol I and II transcription Key words: histone variants, H2A.B, chromatin, transcription, RNA Polymerase 1 bioRxiv preprint doi: https://doi.org/10.1101/2021.01.19.427265; this version posted January 20, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved.